Bokslutskommuniké for Cline Scientific AB (publ), 556867-8238, for the period 1 January - 31 December 2022
Cline Scientific AB (publ) ("Cline" or the "Company") issues the following bokslutskommuniké for 2022.
- Net sales amounted to 0 (0) SEK.
- Operating profit amounted to 237,140 (-143,519) SEK
- Profit per average number of shares after tax amounted to 0.01 (-0.01)
- Net sales amounted to 0 (3,991) SEK.
- Operating profit amounted to -2,317,061 (-3,503,694) SEK
- Profit per average number of shares after tax amounted to -0.15 (-0.24)
The report is published at www.clinescientific.com/financial-reports
The company is listed on the Nasdaq First North Growth Market. Redeye AB is Cline Scientific's Certified Adviser. The information was submitted for publication via the contact person listed above, at 8.30am CET on 17 February 2023.
For more information, please contact:
Patrik Sundh, CEO
Email: patrik.sundh@clinescientific.com
Phone: +46 703-585088